STOCK TITAN

Viatris Inc. to Release First Quarter 2022 Financial Results on May 9, 2022

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Viatris Inc. (NASDAQ: VTRS) will announce its Q1 2022 financial results on May 9, 2022, before U.S. market opening. The announcement will be followed by a live webcast at 8:30 a.m. EDT, featuring executives including CEO Michael Goettler and CFO Sanjeev Narula. The company aims to provide insights on its performance since being formed in November 2020, leveraging extensive expertise to deliver high-quality medicines globally.

Positive
  • None.
Negative
  • None.

PITTSBURGH, April 8, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) plans to release its first quarter 2022 financial results on Monday, May 9, before the open of the U.S. financial markets. Chief Executive Officer Michael Goettler, President Rajiv Malik, and Chief Financial Officer Sanjeev Narula also will host a webcast at 8:30 a.m. EDT on May 9 to discuss the results.

Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 866.342.8591 or 203.518.9713 for international callers (Conference ID: VTRSQ122). A replay of the webcast also will be available on the website.

About Viatris 
Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a portfolio of biosimilars and a variety of over-the-counter consumer products. With a global workforce of approximately 37,000, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisIncLinkedIn and YouTube

Viatris Logo (PRNewsfoto/Viatris Inc.)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-inc-to-release-first-quarter-2022-financial-results-on-may-9-2022-301520622.html

SOURCE Viatris Inc.

FAQ

When will Viatris release its first quarter 2022 financial results?

Viatris will release its first quarter 2022 financial results on May 9, 2022.

What time is the Viatris Q1 2022 earnings call?

The Viatris Q1 2022 earnings call is scheduled for 8:30 a.m. EDT on May 9, 2022.

How can I listen to the Viatris earnings webcast?

Investors can listen to the Viatris earnings webcast at investor.viatris.com or by calling 866.342.8591.

Who will be speaking during the Viatris earnings call?

The speakers during the Viatris earnings call will include CEO Michael Goettler, President Rajiv Malik, and CFO Sanjeev Narula.

What is the ticker symbol for Viatris?

The ticker symbol for Viatris is VTRS.

Viatris Inc.

NASDAQ:VTRS

VTRS Rankings

VTRS Latest News

VTRS Stock Data

14.66B
1.19B
0.41%
82.85%
1.74%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
CANONSBURG